Literature DB >> 2146746

Fibrinolysis and cancer.

H C Kwaan1, H N Keer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2146746     DOI: 10.1055/s-2007-1002674

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


× No keyword cloud information.
  15 in total

Review 1.  Non-tissue factor procoagulants in cancer cells.

Authors:  S G Gordon; M Chelladurai
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

Review 2.  The hypercoagulable state of malignancy: pathogenesis and current debate.

Authors:  Graham J Caine; Paul S Stonelake; Gregory Y H Lip; Sean T Kehoe
Journal:  Neoplasia       Date:  2002 Nov-Dec       Impact factor: 5.715

3.  Diagnostic laparoscopy of patient with deep vein thrombosis before diagnosis of ovarian cancer: a case report.

Authors:  Jae Eun Ha; Yong Seok Lee; Hae Nam Lee; Eun Kyung Park
Journal:  Cancer Res Treat       Date:  2010-03-31       Impact factor: 4.679

Review 4.  Pathogenesis of thrombosis in patients with malignancy.

Authors:  A Falanga; M B Donati
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

Review 5.  Impact of venous thromboembolism and anticoagulation on cancer and cancer survival.

Authors:  Nicole M Kuderer; Thomas L Ortel; Charles W Francis
Journal:  J Clin Oncol       Date:  2009-09-08       Impact factor: 44.544

6.  Clinical significance of the ratio between the alpha 2 plasmin inhibitor-plasmin complex and the thrombin-antithrombin complex in advanced non-small cell lung cancer.

Authors:  Katsuhiro Masago; Shiro Fujita; Tadashi Mio; Yosuke Togashi; Young Hak Kim; Yukimasa Hatachi; Akiko Fukuhara; Kaoru Irisa; Yuichi Sakamori; Michiaki Mishima
Journal:  Med Oncol       Date:  2010-03-19       Impact factor: 3.064

7.  Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study.

Authors:  Boris Dickmann; Jonas Ahlbrecht; Cihan Ay; Daniela Dunkler; Johannes Thaler; Werner Scheithauer; Peter Quehenberger; Christoph Zielinski; Ingrid Pabinger
Journal:  Haematologica       Date:  2013-04-12       Impact factor: 9.941

8.  Comparison of the serum fibrin-fibrinogen degradation products with cytokeratin 19 fragment as biomarkers in patients with lung cancer.

Authors:  Hee Jin So; Seok-Il Hong; Jin Kyung Lee; Yoon Hwan Chang; Sun Jung Kang; Young Jun Hong
Journal:  Biomed Rep       Date:  2014-07-11

Review 9.  Fibrinolytic mechanisms in tumor growth and spreading.

Authors:  T Südhoff; W Schneider
Journal:  Clin Investig       Date:  1992-08

Review 10.  The plasminogen-plasmin system in malignancy.

Authors:  H C Kwaan
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.